CPA3 and asthma: Taken together, we here demonstrated that deletion of Cpa3 did not have an impact on AHR, inflammatory cell infiltration in BAL, peribronchial mast cell number and degranulation, cytokines in lung tissue, goblet cell hyperplasia, smooth muscle remodeling or serum levels of specific IgE in two models of asthma.